Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.18)
# 1944
Out of 5,370 analysts
209
Total ratings
51.43%
Success rate
-3.68%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IRTC iRhythm Technologies | Maintains: Overweight | 130 160 | 144.35 | 10.84% | 16 | Jun 11, 2025 | |
ZBH Zimmer Biomet Holdin... | Maintains: Equal-Weight | 115 95 | 92.12 | 3.13% | 12 | May 6, 2025 | |
NVRO Nevro | Downgrades: Underweight | 9 4 | n/a | n/a | 9 | Dec 2, 2024 | |
ISRG Intuitive Surgical | Upgrades: Overweight | 522 650 | 518.65 | 25.33% | 13 | Dec 2, 2024 | |
SGHT Sight Sciences | Maintains: Equal-Weight | 7 5 | 4.22 | 18.48% | 15 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 13 12 | 10.03 | 19.64% | 12 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 75 95 | 141.56 | -32.89% | 12 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 104 98 | 87.94 | 11.44% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 76 69 | n/a | n/a | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 83 83 | n/a | n/a | 10 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 1 | n/a | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 78 85 | 86.02 | -1.19% | 9 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 224 291 | n/a | n/a | 6 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 15 | 28.69 | -47.72% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 325 343 | 305.89 | 12.13% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 14 | 2.97 | 371.38% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 44 48 | 30.74 | 56.15% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 102 | 74.71 | 36.53% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 56 58 | 101.47 | -42.84% | 16 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 20 | 12.23 | 63.53% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 117 131 | 83.28 | 57.3% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 133.99 | -0.74% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 235 380 | n/a | n/a | 2 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 270 220 | 376.8 | -41.61% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 383 378 | 121.02 | 212.35% | 2 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 29 25 | n/a | n/a | 3 | Jan 7, 2022 |